A detailed history of Walleye Capital LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 129,687 shares of RXST stock, worth $5.81 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
129,687
Previous 18,006 620.24%
Holding current value
$5.81 Million
Previous $1.08 Million 491.87%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.78 - $57.04 $4.55 Million - $6.37 Million
111,681 Added 620.24%
129,687 $6.41 Million
Q2 2024

Aug 14, 2024

SELL
$50.42 - $64.29 $340,587 - $434,278
-6,755 Reduced 27.28%
18,006 $1.08 Million
Q1 2024

May 15, 2024

SELL
$35.51 - $57.92 $2.34 Million - $3.82 Million
-66,001 Reduced 72.72%
24,761 $1.28 Million
Q4 2023

Feb 14, 2024

BUY
$20.91 - $40.9 $1.9 Million - $3.71 Million
90,762 New
90,762 $3.66 Million
Q2 2023

Aug 14, 2023

BUY
$16.37 - $28.9 $256,665 - $453,123
15,679 New
15,679 $451,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.